Table 2 showed FIGO stage of the studied woman, 40% of the patients had stage 3 and the serum levels of HE4 and CA125 in relation to histological types with higher significant level in serous ovarian cancer (p <0.01 and p <0.05 respectively). This evidence concerns the gene WFDC2 and ovarian serous adenocarcinoma.